Literature DB >> 26180016

Imbalance of tumor necrosis factor-α, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea.

Yanbo Zhen1, Chuanlian Chu1, Shiqing Zhou1, Ming Qi1, Ronghua Shu1.   

Abstract

The present study aimed to explore the correlation between cytokine expression of tumor necrosis factor α (TNF‑α), interleukin (IL)‑8 and IL‑10 with occludin production, abdominal symptoms and psychological factors in patients with irritable bowel syndrome‑associated diarrhea (IBS‑D). A total of 42 IBS‑D patients and 20 healthy controls were included, which were recruited from QiLu Hospital in China. ELISA and immunohistochemical analysis were performed for evaluating the cytokines (TNF‑α, IL‑8 and IL‑10) and occludin protein levels in the peripheral blood mononuclear cells (PBMCs) of all subjects. In addition, the abdominal symptoms and psychological status were assessed in IBS‑D patients. Levels of TNF‑α and IL‑8 in the PBMCs of patients with IBS‑D were significantly higher than those in the controls (P<0.001 and P=0.007, respectively), while IL‑10 levels were significantly reduced in patients with IBS‑D (P=0.047). Occludin production was significantly reduced in patients with IBS‑D as compared with that in the controls (P<0.001). In patients with IBS‑D, levels of TNF‑α and IL‑8 were negatively correlated with occludin levels (r=‑0.34, P=0.028; r=‑0.52, P<0.001, respectively). IL‑10 showed a negative correlation with occludin production (r=0.05, P=0.748). Furthermore, TNF‑α, IL‑8 and IL‑10 levels were significantly correlated with symptoms scores (r=0.74, P<0.001; r=0.55, P<0.001; r=‑0.80, P<0.001, respectively) in patients with IBS‑D. Within the IBS‑D group, TNF‑α expression was significantly increased in patients with a self‑rating depression scale (SDS) score ≥50 (P=0.004) as compared with that in patients with an SDS score <50. Furthermore, IL‑8 was significantly increased in IBS‑D patients with a self‑rating anxiety scale (SAS) or SDS score ≥50 (P=0.016, P=0.008, respectively) as compared with that in patients scoring <50. In conclusion, the results of the present study suggested that in IBS‑D, an imbalance of cytokine production evoked colonic epithelial barrier dysfunction, abdominal symptoms and psychological disorders.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26180016     DOI: 10.3892/mmr.2015.4079

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


  16 in total

1.  Activation of 5-HT and NR2B contributes to visceral hypersensitivity in irritable bowel syndrome in rats.

Authors:  Ming-Xian Chen; Yu Chen; Rui Fu; Sai-Yue Liu; Qin-Qin Yang; Tang-Biao Shen
Journal:  Am J Transl Res       Date:  2016-12-15       Impact factor: 4.060

2.  Biomarkers of chronic inflammation in disease development and prevention: challenges and opportunities.

Authors:  Christina H Liu; Natalie D Abrams; Danielle M Carrick; Preethi Chander; Johanna Dwyer; Michelle R J Hamlet; Francesca Macchiarini; Mercy PrabhuDas; Grace L Shen; Pushpa Tandon; Merriline M Vedamony
Journal:  Nat Immunol       Date:  2017-10-18       Impact factor: 25.606

3.  Cytokine Gene Polymorphisms Associated With Symptom Clusters in Oncology Patients Undergoing Radiation Therapy.

Authors:  Christine Miaskowski; Yvette P Conley; Judy Mastick; Steven M Paul; Bruce A Cooper; Jon D Levine; Mitchell Knisely; Kord M Kober
Journal:  J Pain Symptom Manage       Date:  2017-08-08       Impact factor: 3.612

Review 4.  The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders.

Authors:  Tibor Docsa; Adám Sipos; Charles S Cox; Karen Uray
Journal:  Int J Mol Sci       Date:  2022-06-22       Impact factor: 6.208

Review 5.  A meta-analysis and systematic review of the comorbidity between irritable bowel syndrome and bipolar disorder.

Authors:  Ping-Tao Tseng; Bing-Syuan Zeng; Yen-Wen Chen; Ming-Kung Wu; Ching-Kuan Wu; Pao-Yen Lin
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

Review 6.  Current insights into the innate immune system dysfunction in irritable bowel syndrome.

Authors:  Nikolaos Lazaridis; Georgios Germanidis
Journal:  Ann Gastroenterol       Date:  2018-01-18

7.  Changes in the serum levels of inflammatory cytokines in antidepressant drug-naïve patients with major depression.

Authors:  Wei Zou; Renjie Feng; Yuan Yang
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

8.  Adipose Tissue-Derived Biomarkers of Intestinal Barrier Functions for the Characterization of Diarrhoea-Predominant IBS.

Authors:  Francesco Russo; Guglielmina Chimienti; Giuseppe Riezzo; Michele Linsalata; Benedetta D'Attoma; Caterina Clemente; Antonella Orlando
Journal:  Dis Markers       Date:  2018-11-28       Impact factor: 3.434

9.  Underlying molecular and cellular mechanisms in childhood irritable bowel syndrome.

Authors:  Bruno P Chumpitazi; Robert J Shulman
Journal:  Mol Cell Pediatr       Date:  2016-02-16

Review 10.  Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis.

Authors:  S P Leighton; L Nerurkar; R Krishnadas; C Johnman; G J Graham; J Cavanagh
Journal:  Mol Psychiatry       Date:  2017-11-14       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.